RICHARDSON, TEXAS — ANDREW, a hardware manufacturer for the telecommunications industry, has signed a 42,000-square-foot lease in the northeastern Dallas suburb of Richardson. The company is relocating from the nearby building at 2601 Telecom Parkway to the flex building at 2920 Telecom Parkway. In addition to office, the company’s new space supports lab, manufacturing and engineering uses. As part of the relocation, ANDREW plans to invest more than $2 million to support tenant improvements and the addition of new furniture, fixtures and equipment at its new Richardson facility.
WALTHAM, MASS. — Biocytogen, which provides animal and cell model generation for preclinical research, has signed a 35,000-square-foot life sciences lease in Waltham, a western suburb of Boston. Biocytogen now occupies about 70,000 square feet at the 143,533-square-foot building at 300 Third Ave. Tim Allen of Colliers represented the tenant in the lease negotiations. Tim Latham, Christopher Scott and Chris Devaux represented the landlord, Dallas-based Lincoln Property Co., on an internal basis.
BEDFORD, MASS. — A joint venture between Anchor Line Partners and Alloy Properties has refinanced The Core at Crosby, a 615,305-square-foot office and life sciences campus in Bedford, a northwestern suburb of Boston. Berlin Hyp, the commercial real estate finance arm of LBBW, provided the debt for the nine-building campus, which is anchored by software provider AspenTech. Robert Griffin, David Douvadjian Sr., David Douvadjian Jr., Timothy O’Donnell, Edward Maher and Matthew Pullen of Newmark arranged the debt on behalf of the joint venture.
DURHAM, N.C. — Biopharmaceutical company AbbVie (NYSE: ABBV) has announced plans for a new pharmaceutical manufacturing campus located in Durham, according to North Carolina Gov. Josh Stein. AbbVie will invest $1.4 billion in the project over four years, marking the company’s largest capital commitment for a single campus to date and its first investment in the Tarheel State. Last year, AbbVie unveiled plans for a $195 million expansion its manufacturing plan in its hometown of North Chicago. Both projects are part of AbbVie’s $100 billion commitment to grow its U.S. research-and-development and capital investments over the next decade. Upon completion, the Durham campus will total 185 acres and will include drug product manufacturing facilities, next-generation laboratories, a warehouse, administrative offices and employee wellness facilities. AbbVie plans to produce small volume parenteral (i.e. prefilled syringes and vials for injection or infusion) drug products at the facility. Construction of the Durham campus is scheduled to begin this year and be completed by the end of 2028. AbbVie expects the construction process to support 2,000 temporary jobs. Several state and local entities, including The North Carolina Department of Commerce and the Economic Development Partnership of North Carolina, have collaborated with AbbVie on the project. AbbVie …
PHILADELPHIA — Brandywine Realty Trust has received $87.3 million in C-PACE financing for 3151 Market Street, a 494,530-square-foot life sciences facility located within the developer’s Schuylkill Yards mixed-use destination in Philadelphia. The newly completed facility also includes traditional office space in addition to lab facilities and various tenant amenities. Nuveen Green Capital provided the financing, and the deal team says that the amount represents the largest C-PACE loan closing in Pennsylvania’s history. The Philadelphia Energy Authority will administer the financing.
DACULA, GA. — Global biopharmaceutical company UCB has unveiled plans to invest $2 billion to establish its first U.S. pharmaceutical biologics manufacturing campus in Dacula, a city within metro Atlanta’s Gwinnett County. The new facility is expected to create 330 new jobs over the next several years at Rowen, a mixed-use innovation district focused on global health, agriculture and environmental sustainability. The 2,000-acre “knowledge community” is planned along Ga. Highway 316. The new 460,000-square-foot facility will anchor 79 acres that UCB purchased off Rowen Parkway. Brussels, Belgium-based UCB maintains an existing presence in Georgia. The company’s North American headquarters is located in Smyrna and currently supports more than 400 jobs spanning expertise in neurology and immunology. UCB is focused on developing innovative medicines for people living with severe neurological and autoimmune conditions such as epilepsy. UCB’s new manufacturing footprint marks the first major private investment at Rowen and the largest capital investment in Gwinnett County’s history. UCB says it will leverage advanced manufacturing technologies, including artificial intelligence, robotics and automation, while prioritizing efficient use of natural resources. Jean-Christophe Tellier, CEO of UCB, says the project is expected to generate approximately $5 billion in total economic impact, including more than 1,000 …
BEVERLY, MASS. — American Surgical Co. has signed a 20,325-square-foot life sciences lease in Beverly, a northeastern suburb of Boston. The provider of medical tools is relocating from Shetland Park in nearby Salem to 100 Cummings Center, a newly built, 1.3 million-square-foot research-and-development facility. Joe Doyle and John Coakley of Cresa represented the tenant in the lease negotiations. Al Diamond represented the landlord, Cummings Properties, on an internal basis.
PLANO, TEXAS — Riken Vitamin Co. has signed a 12,653-square-foot lease in Plano. The Japanese producer of food additives and vitamins is relocating from California to R&D at Legacy, a 374,275-square-foot flex development. Doug Carignan and Landon Brune of CBRE represented the tenant in the lease negotiations. Chase Lopez, James Mantzuranis and Sam Bass of Stream Realty Partners represented the landlord, BH Properties.
LEXINGTON, MASS. — Nortiva Bio has signed a 22,881-square-foot life sciences lease renewal in Lexington, located northwest of Boston. The biopharmaceutical company’s space is located on the third floor of 20 Maguire Road, a 101,310-square-foot converted building. Alex Plaisted and Don Domoretsky of CBRE represented the landlord, a partnership between Investcorp and Griffith Properties, in the lease negotiations.
LEXINGTON, MASS. — Convatec has signed a life sciences lease expansion and extension in Lexington, located northwest of Boston. The medical products and technology company now occupies 24,572 square feet on the second floor of 20 Maguire Road, a 101,310-square-foot converted building. Alex Plaisted and Don Domoretsky of CBRE represented the landlord, a partnership between Investcorp and Griffith Properties, in the lease negotiations.
Newer Posts